MedPath

A clinical trial to study the effect of lajjalumoola taila in post-operative fistulotomy wounds.

Phase 2
Not yet recruiting
Conditions
Health Condition 1: K603- Anal fistula
Registration Number
CTRI/2023/06/053652
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Subjects who undergo elective fistulotomy in case of low anal fistula, with a wound length of at least 2 cms; as per Parkâ??s classification, intersphincteric and low transphincteric fistula involving less than 1/3rd of external anal sphincter fibres are included.

2.Selection of subjects will be done irrespective of sex, religion, occupation, economic and educational status.

Exclusion Criteria

1. Subjects who have undergone fistulotomy in case of secondary anal fistula caused by specific pathology such as Inflammatory Bowel Disease, Crohnâ??s disease, Tuberculosis are to be excluded.

2. Positive cases for Human Immunodeficiency Virus (HIV), Venereal Disease Research Laboratory (VDRL) and Hepatitis-B.

3. Subjects with symptoms of faecal incontinence are to be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath